24 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32021384 | The Effect of UGT1A9, CYP2B6 and CYP2C9 Genes Polymorphism on Propofol Pharmacokinetics in Children. | 2020 | 3 |
2 | 33816071 | Influence of Potential Gene Polymorphisms on Propofol Dosage Regimen in Patients Undergoing Abdominal Hysterectomy. | 2020 Nov | 2 |
3 | 29468507 | Impact of clinical factors and UGT1A9 and CYP2B6 genotype on inter-individual differences in propofol pharmacokinetics. | 2018 Apr | 2 |
4 | 32025958 | Effect of sex and polymorphisms of CYP2B6 and UGT1A9 on the difference between the target-controlled infusion predicted and measured plasma propofol concentration. | 2018 Aug 13 | 2 |
5 | 27826892 | The effect of UGT1A9, CYP2B6 and CYP2C9 genes polymorphism on individual differences in propofol pharmacokinetics among Polish patients undergoing general anaesthesia. | 2017 May | 2 |
6 | 28154789 | CYP2B6 Genotype Guided Dosing of Propofol Anesthesia in the Elderly based on Nonparametric Population Pharmacokinetic Modeling and Simulations. | 2017 | 4 |
7 | 29133890 | Longrange PCR-based next-generation sequencing in pharmacokinetics and pharmacodynamics study of propofol among patients under general anaesthesia. | 2017 Nov 13 | 2 |
8 | 26141406 | Impact of the Cytochrome P450 2B6 (CYP2B6) Gene Polymorphism c.516G>T (rs3745274) on Propofol Dose Variability. | 2016 Oct | 6 |
9 | 27362518 | Pharmacogenetics of Anesthesia: An Integrative Review. | 2016 Jul-Aug | 2 |
10 | 27709010 | Insights into CYP2B6-mediated drug-drug interactions. | 2016 Sep | 1 |
11 | 27749294 | A Case of Delayed Emergence After Propofol Anesthesia: Genetic Analysis. | 2016 Dec 1 | 3 |
12 | 26307675 | Application of HC-AFW1 Hepatocarcinoma Cells for Mechanistic Studies: Regulation of Cytochrome P450 2B6 Expression by Dimethyl Sulfoxide and Early Growth Response 1. | 2015 Nov | 1 |
13 | 24153159 | Association of the CYP2B6 c.516G>T polymorphism with high blood propofol concentrations in women from northern Greece. | 2014 | 2 |
14 | 23640947 | The impact of genetic factors on response to anaesthetics. | 2013 | 1 |
15 | 21301907 | Analysis of clinically relevant substrates of CYP2B6 enzyme by computational methods. | 2011 Nov | 4 |
16 | 21869535 | Individual differences in pharmacokinetics and pharmacodynamics of anesthetic agent propofol with regard to CYP2B6 and UGT1A9 genotype and patient age. | 2011 | 5 |
17 | 19442086 | Polymorphic drug metabolism in anaesthesia. | 2009 Mar | 1 |
18 | 19702527 | Substrate specificity, regulation, and polymorphism of human cytochrome P450 2B6. | 2009 Sep | 1 |
19 | 18781911 | CYP2B6: new insights into a historically overlooked cytochrome P450 isozyme. | 2008 Sep | 1 |
20 | 17620218 | Involvement of human cytochrome P450 2B6 in the omega- and 4-hydroxylation of the anesthetic agent propofol. | 2007 Jul | 9 |
21 | 17073575 | The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico. | 2006 Oct | 1 |
22 | 17101742 | Evaluation of 227 drugs for in vitro inhibition of cytochrome P450 2B6. | 2006 Dec | 2 |
23 | 11135730 | Cytochrome P-450 2B6 is responsible for interindividual variability of propofol hydroxylation by human liver microsomes. | 2001 Jan | 5 |
24 | 11298076 | Involvement of human liver cytochrome P4502B6 in the metabolism of propofol. | 2001 Mar | 5 |